A detailed history of C2 C Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, C2 C Wealth Management, LLC holds 1,245 shares of AMGN stock, worth $331,792. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,245
Previous 1,245 -0.0%
Holding current value
$331,792
Previous $389,000 3.08%
% of portfolio
0.37%
Previous 0.38%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $537,740 - $649,120
-2,000 Reduced 61.63%
1,245 $353,000
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $11,506 - $12,980
45 Added 1.41%
3,245 $934,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $451,580 - $550,400
2,000 Added 166.67%
3,200 $773,000
Q3 2022

Oct 12, 2022

SELL
$224.46 - $253.15 $67,338 - $75,945
-300 Reduced 20.0%
1,200 $280,000
Q4 2021

Feb 23, 2022

BUY
$198.88 - $227.6 $298,320 - $341,400
1,500 New
1,500 $337,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $143B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track C2 C Wealth Management, LLC Portfolio

Follow C2 C Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C2 C Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on C2 C Wealth Management, LLC with notifications on news.